THW
Get informed when a big investor buys or sells
+ FollowOvervalued by 9.7% based on the discounted cash flow analysis.
| Market cap | $548.29 Million |
|---|---|
| Enterprise Value | $668.29 Million |
| Dividend Yield | $1.40 (10.30%) |
| Earnings per Share | $1.43 |
| Beta | 0.81 |
| Outstanding Shares | 40,344,913 |
| P/E Ratio | 6.12 |
|---|---|
| PEG | -6.95 |
| Price to Sales | 6.59 |
| Price to Book Ratio | 1.2 |
| Enterprise Value to Revenue | 5.83 |
| Enterprise Value to EBIT | 7.06 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.25 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.65%▼ 14.10% |
|---|---|
| Total Invested | $3.52M▼ 94.72% |
| Investors Holding | 4▼ 80.00% |
No data
Tekla World Healthcare Fund is a closed-end fund that invests in companies in the healthcare industry. Tekla Capital Management LLC, based in Boston, serves as investment adviser to the Fund.